Lexicon Pharmaceuticals
LXRX
#6610
Rank
HK$5.18 B
Marketcap
HK$12.23
Share price
-3.70%
Change (1 day)
337.13%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2025 (TTM): -HK$0.54 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are HK$70.86 Million. In 2024 the company made an earning of -HK$1.58 Billion a decrease over its 2023 earnings that were of -HK$1.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.54 Billion-66.08%
2024 -HK$1.58 Billion13.15%
2023 -HK$1.39 Billion73.74%
2022 -HK$0.8 Billion16.16%
2021 -HK$0.69 Billion49.82%
2020 -HK$0.46 Billion-147.19%
2019 HK$0.97 B-203.42%
2018 -HK$0.95 Billion-15.31%
2017 -HK$1.12 Billion0.2%
2016 -HK$1.11 Billion2920.7%
2015 -HK$36.7 Million-95.33%
2014 -HK$0.79 Billion-3.61%
2013 -HK$0.82 Billion-5.52%
2012 -HK$0.87 Billion-4.17%
2011 -HK$0.91 Billion15.5%
2010 -HK$0.79 Billion8.36%
2009 -HK$0.73 Billion-4.81%
2008 -HK$0.76 Billion28.79%
2007 -HK$0.59 Billion35.71%
2006 -HK$0.44 Billion52.91%
2005 -HK$0.29 Billion-23.89%
2004 -HK$0.38 Billion-24.19%
2003 -HK$0.5 Billion-0.48%
2002 -HK$0.5 Billion44.12%
2001 -HK$0.35 Billion23.01%
2000 -HK$0.28 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
HK$55.61 B-10,447.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$7.79 B-1,550.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$40.99 B-7,727.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-HK$4.07 Billion 656.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$0.52 B-197.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-HK$0.22 Billion-59.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-HK$0.19 Billion-66.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$5.32 B-1,090.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-HK$74.38 Million-86.16%๐Ÿ‡บ๐Ÿ‡ธ USA